CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival

Por Koelzer, Viktor H, Lugli, Alessandro, Dawson, Heather, Hädrich, Marion, Berger, Martin D, Borner, Markus, Mallaev, Makhmudbek, Galván, José A, Amsler, Jennifer, Schnüriger, Beat, Zlobec, Inti, Inderbitzin, Daniel
Publicado em 2014

TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer

Por Galván, José A., Helbling, Melina, Koelzer, Viktor H., Tschan, Mario P., Berger, Martin D., Hädrich, Marion, Schnüriger, Beat, Karamitopoulou, Eva, Dawson, Heather, Inderbitzin, Daniel, Lugli, Alessandro, Zlobec, Inti
Publicado no Oncotarget (2014)

Prognostic Impact of IL-6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy

Por Matsusaka, Satoshi, Hanna, Diana L., Cao, Shu, Zhang, Wu, Yang, Dongyun, Ning, Yan, Sunakawa, Yu, Okazaki, Satoshi, Berger, Martin D., Miyamato, Yuji, Parekh, Anish, Stintzing, Sebastian, Loupakis, Fotios, Lenz, Heinz-Josef
Publicado no Clin Cancer Res (2016)

Cytokeratin-20 and Survivin Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach

Por Ning, Yan, Hanna, Diana L, Zhang, Wu, Mendez, Angela, Yang, Dongyun, El-Khoueiry, Rita, Matsusaka, Satoshi, Sunakawa, Yu, Stremitzer, Stefan, Parekh, Anish, Okazaki, Satoshi, Berger, Martin D., Barzi, Afsaneh, Lenz, Heinz-Josef
Publicado no Mol Cancer Ther (2015)

TWIST1 polymorphisms predict survival in patients with metastatic colorectal cancer receiving first-line bevacizumab plus oxaliplatin-based chemotherapy

Por Matsusaka, Satoshi, Zhang, Wu, Cao, Shu, Hanna, Diana L., Sunakawa, Yu, Sebio, Ana, Ueno, Masashi, Yang, Dongyun, Ning, Yan, Parekh, Anish, Okazaki, Satoshi, Berger, Martin D., Ichikawa, Wataru, Mizunuma, Nobuyuki, Lenz, Heinz-Josef.
Publicado no Mol Cancer Ther (2016)

VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer

Por Schafroth, Christian, Galván, José A., Centeno, Irene, Koelzer, Viktor H., Dawson, Heather E., Sokol, Lena, Rieger, Gregor, Berger, Martin D., Hädrich, Marion, Rosenberg, Robert, Nitsche, Ulrich, Schnüriger, Beat, Langer, Rupert, Inderbitzin, Daniel, Lugli, Alessandro, Zlobec, Inti
Publicado no Oncotarget (2015)

Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012

Por Berger, Martin D., Yang, Dongyun, Sunakawa, Yu, Zhang, Wu, Ning, Yan, Matsusaka, Satoshi, Okazaki, Satoshi, Miyamoto, Yuji, Suenaga, Mitsukuni, Schirripa, Marta, Lenz, Annika Medea, Bohanes, Pierre, Barzi, Afsaneh, Figueiredo, Jane C., Hanna, Diana L., Lenz, Heinz-Josef
Publicado no Oncotarget (2016)

Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of...

Por Helbling, Melina, Lukesch, Anne, Haimovici, Aladin, Karamitopoulou, Eva, Berger, Martin D., Hädrich, Marion, Mallaev, Makhmud, Schnüriger, Beat, Koelzer, Viktor H., Dawson, Heather, Borner, Markus, Langer, Rupert, Rosenberg, Robert, Nitsche, Ulrich, Inderbitzin, Daniel, Lugli, Alessandro, Tschan, Mario P., Zlobec, Inti
Publicado em 2014

Clinical significance of TLR1 I602S polymorphism for patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab

Por Okazaki, Satoshi, Loupakis, Fotios, Stintzing, Sebastian, Cao, Shu, Zhang, Wu, Yang, Dongyun, Ning, Yan, Sunakawa, Yu, Stremitzer, Stefan, Matsusaka, Satoshi, Berger, Martin D., Parekh, Anish, West, Jordan D., Miyamoto, Yuji, Suenaga, Mitsukuni, Schirripa, Marta, Cremolini, Chiara, Falcone, Alfredo, Heinemann, Volker, DePaolo, R. William, Lenz, Heinz-Josef
Publicado no Mol Cancer Ther (2016)